A global pharmaceutical company with operations spanning India, Asia, Africa, the Middle East, and the United States delivers affordable healthcare solutions across cardiology, dermatology, ophthalmology, and pain management.
With eco-friendly manufacturing and advanced R&D at its core, the company had the sustainability intent — but not the infrastructure. ESG data was fragmented across facilities, Scope 3 tracking across suppliers and logistics partners was resource-intensive, and spreadsheet-heavy processes were creating audit gaps at precisely the moment BRSR Core compliance was becoming non-negotiable.
Download the case study to explore:
- The data fragmentation, Scope 3 complexity, and audit readiness gaps the company needed to close across its global operations
- How Credibl deployed an AI-powered platform with pharma-specific KPIs, multi-level approval workflows, Scope 3 tracking, and BRSR Core-aligned templates
- The outcomes — including improved data accuracy, successful third-party verification, and streamlined compliance across both Indian and international frameworks